AKBA
Akebia Therapeutics, Inc.macro factor on the upper side for the current regime, with momentum factor near the top of its range.
AKBA ranks #2 out of 2 health care stocks in the Tapeline universe by composite score this session.
Score breakdown · six named factors
The six factors are public and never change without a changelog entry. Read the full methodology on /how-it-works.
What the score says about AKBA right now
Akebia Therapeutics, Inc. (AKBA) currently scores 58/100 on the Tapeline six-factor composite, sitting in the CONSTRUCTIVE band. AKBA is +2.78% on the day and -5.27% over five sessions as of the most recent tick. CONSTRUCTIVE (55-69) is the "watchlist tier" — net positive with meaningful tradeoffs. AKBA is interesting but not bid up. For value or contrarian setups this is often the most actionable band — quality without the late-stage price-discovery overhead. AKBA's strongest factor is Macro at 76/100 — meaning the broader regime (rates, VIX, dollar, breadth) is strong supportive for this kind of setup. Macro doesn't move stocks directly but it sets the tempo for everything underneath. The weakest factor is Relative Strength at 42/100 — middling performance vs SPY and the sector. AKBA is participating in any rally less than its peers.
Generated from the live six-factor breakdown above. Updates as the underlying scores re-tick during US market hours. Methodology detail at /how-it-works.
See AKBA in the live scanner
Free signup gives you live scores for the top 10 scanner rows and 12 look-ups a day — free forever, no card. Pro unlocks the full ~2,500-ticker real-time scanner with unlimited look-ups and smart alerts; Premium adds congressional trades and recent insider buys (SEC Form 4).
Recent AKBA news
Latest market-moving headlines mentioning AKBA, sourced from Tapeline’s news feed (Polygon/Massive + Finnhub).
- Akebia: Vafseo Gains Traction, But It's Still A Show-Me Story (Rating Downgrade)SeekingAlpha
- HC Wainwright & Co. Reiterates Buy on Akebia Therapeutics, Maintains $6 Price TargetBenzinga
- Akebia Therapeutics, U.S. Renal Care Announce U.S. Renal Care Kidney Research Proposed To Halt Vafseo Outcomes In Center Experience Study After Planned Interim Analysis Based On Recommendation From Independent Data Monitoring Committee, Trial Steering CommitteeBenzinga
- Acute Kidney Injury Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsightGlobeNewswire Inc.+1 other ticker
- Akebia Therapeutics Granted New Patent And Listed In Orange Book; Notified Of Eligibility To Extend Expiration Of Composition Of Matter Patent Covering VafseoBenzinga
News refreshes every 5 minutes during US market hours.
Similar setups in Health Care right now
Six health care tickers with composite scores closest to AKBA’s 58 — same factor environment, sortable on the live scanner.
Sorted by closeness to AKBA’s composite score within Health Care. Refreshed every 5 minutes. Run the full scanner →
Frequently asked about AKBA
What is the Tapeline Score for AKBA?
+
AKBA (Akebia Therapeutics, Inc.) currently scores 58/100 with the signal label CONSTRUCTIVE. The score is a weighted blend of six quantitative factors and updates sub-60 seconds during US market hours.
How is AKBA's score calculated?
+
The Tapeline Score is a transparent weighted blend of six named factors: Trend, Relative Strength, Fundamentals, Smart Money, Macro, and Momentum — weighted most toward Trend and Relative Strength, and least toward Momentum. Each sub-score is normalised to 0-100 and the methodology is published on /how-it-works.
Is AKBA a buy?
+
Tapeline doesn't issue buy or sell calls — we publish descriptive analytics, not investment advice. The signal label CONSTRUCTIVE describes the current state of the data; whether AKBA fits your portfolio depends on your risk tolerance, time horizon, and tax situation. See the risk disclosure for details.
How often does the AKBA score update?
+
AKBA's score re-ticks every minute during US market hours and persists between sessions. Price and momentum data refresh sub-60s; fundamentals refresh on company filing cadence; insider Form 4 within hours of SEC filing.
Where can I see the historical track record for Tapeline scores?
+
Every Tapeline top-10 daily pick is auto-published with the next-day return vs SPY at /scorecard. The scorecard is immutable — every call is preserved with its original context for accountability.
What does the CONSTRUCTIVE signal mean for AKBA?
+
CONSTRUCTIVE is a descriptive band on the Tapeline composite. HIGH CONVICTION (85-100) means all six factors aligned; STRONG SETUP (70-84) typically four-or-five-of-six; CONSTRUCTIVE (55-69) net-positive with tradeoffs; NEUTRAL (40-54) factors cancel; CAUTION (25-39) more negative than positive; WEAK (0-24) broadly negative. AKBA sitting at CONSTRUCTIVE means the data right now reads as constructive for the six-factor profile.
Is AKBA better for swing trading or day trading?
+
The Tapeline composite is calibrated for multi-day setups — the heaviest-weighted factors (Trend, Relative Strength, and Fundamentals) reward stability over a horizon of days-to-weeks. For pure day trading, the 1-day move + sub-momentum factor is more relevant. Use /best-stocks-for/day-traders for the day-trader-sorted view and /best-stocks-for/swing-traders for the multi-day setup view.
Where does AKBA rank in the health care sector?
+
AKBA's sector rank within the health care sector updates live as composite scores re-tick during US market hours — see the rank line near the top of this page. Sector ranks are computed across the actively-scored universe (~2,500 US tickers by daily $-volume) so the cohort is consistent across all the health care sector names Tapeline covers.
Does Tapeline have insider buying data for AKBA?
+
AKBA's Smart Money sub-score blends SEC Form 4 insider transactions, Congressional disclosures where applicable, and ETF/institutional flow signals. Detailed Form 4 history per ticker is a Premium feature; the aggregate Smart Money sub-score is shown on this page for free.
Why does AKBA's score change between visits?
+
Scores re-tick every minute during US market hours. Trend and Relative Strength move with price; Momentum reflects recent rate-of-change; Macro responds to VIX, breadth, and 10Y yield shifts; Smart Money updates on filing cadence; Fundamentals on quarterly earnings cycle. Across a single trading session AKBA's composite can drift 5-15 points in either direction even without major news — that's normal factor breathing, not data error.
Can I get alerts when AKBA's score changes?
+
Yes — Pro tier gets email alerts on configurable triggers (score crosses a threshold, signal label changes, squeeze detected). Premium adds Telegram unlimited and Congressional-trade alerts. The free tier shows live scores for the top 10 scanner rows plus 12 look-ups a day, with 2 browser push alerts; AKBA email or Telegram alerts specifically require Pro or Premium.
How does AKBA's Tapeline Score compare to a Finviz screener result?
+
Finviz exposes raw filter fields — you build a thesis from the data. Tapeline synthesises six factors into one composite + a plain-English Why, so the work is done before you look at the row. Both are useful for different jobs: Finviz Elite for power-user raw-filter scans, Tapeline for daily synthesised rankings + per-pick public scorecard. Many traders use both — see /best-finviz-alternatives for the head-to-head comparison.
Score updated live (sub-60s). Public formula. Public scorecard. Not investment advice — see risk disclosure.
See this ticker scored each market morning
Get the Tapeline daily Top 10 in your inbox. One email, no card, unsubscribe in one click.